By Teddy Rosenbluth Apoorva Mandavilli and Sheryl Gay Stolberg The Trump administration, moving quickly to clamp down on health and science agencies, has canceled a string of scientific meetings ...

We may earn a commission if you make a purchase from the links on this page. The high-end Galaxy S25 Ultra's S Pen doesn't support Bluetooth, so it loses some cool features like remote control for ...

The strategic competition between the United States and the People’s Republic of China (PRC) emerged prominently during Donald Trump’s first administration. Policies such as tariffs and trade ...

By John Ismay Reporting from Washington The Trump administration fired the commandant of the U.S. Coast Guard, Adm. Linda L. Fagan, within 24 hours of President Trump’s inauguration. The admiral ...

The lawsuits were filed against the new administration on Monday as Trump was sworn in for his second term in the White House. Three of the lawsuits argue DOGE is not a government department ...

But while Musk was one of the best things to happen to the Trump campaign, he could end up being one of the worst things to happen to the incoming Trump administration. Placing too much trust ...

The CEO discussed the success of Dupixent and the remarkable achievement of over $13 billion in global sales in 2024, highlighting its commercial advantage and setting a milestone for Sanofi.

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached over $13bn in global sales, which affirms its commercial advantage and sets a milestone ...

Sanofi’s chief executive Paul Hudson discussed the success of Dupixent (dupilumab)and the remarkable achievement of over $13 billion in global sales in 2024, highlighting its commercial advantage and ...

The use of Sanofi’s Dupixent in atopic dermatitis has set a high benchmark for competitors within the space. Credit: marishkaSm via Shutterstock. Sanofi’s participation at the JP Morgan 43rd Annual ...

Furthermore, the successful launch of Dupixent for chronic obstructive pulmonary disease (COPD) has garnered significant coverage from top commercial and Medicare payers, indicating strong market ...